Previous 10 | Next 10 |
2024-05-01 17:55:53 ET Pfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied pharmaceutical company notch double beats on analyst estimates and provide encouraging guidance. The company's s...
2024-05-01 15:54:10 ET Pfizer Inc. (PFE) Q1 2024 Earnings Conference Call May 1, 2024 10:00 am ET Corporate Participants Francesca DeMartino - Chief Investor Relations Officer Albert Bourla - Chairman and Chief Executive Officer David Denton - Chief Financial Off...
2024-05-01 14:41:05 ET Summary Eli Lilly and Company's revenue for the first quarter of 2024 fell short of analysts' expectations, but the company exceeded forecasts on the bottom line. Sales of the company's obesity and diabetes drugs, particularly Mounjaro and Zepbound, saw sign...
2024-05-01 09:10:00 ET U.S. stock index futures on Wednesday pointed to a slightly lower open. All eyes are on the Federal Reserve's monetary policy decision later in the day, followed by chair Jerome Powell's press conference. Here are some stocks to watch on Wednesday: ... ...
2024-05-01 09:00:00 ET Summary April 2024 jobs report expected to show an increase of 250,000 jobs, indicating continued tightness in the labor market. Healthcare sector likely to add jobs, while drug manufacturers may struggle. Construction, government, energy, and beverage i...
2024-05-01 08:37:31 ET More on Pfizer Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1? Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth Pfizer's Doldrums, Just A Bad Case Of COVID-19? Pfizer beats top-line and bottom-line estima...
2024-05-01 07:21:10 ET More on Pfizer Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1? Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth Pfizer's Doldrums, Just A Bad Case Of COVID-19? Pfizer beats top-line and bottom-line estima...
2024-05-01 07:01:09 ET Pfizer Inc. (NYSE: PFE) has announced its financial outcomes for the first quarter of 2024, displaying strong performance in its non-COVID product portfolio. This includes heightened revenues from recent commercial launches and acquired products, alongside a c...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
2024-05-01 06:48:13 ET More on Pfizer Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1? Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth Pfizer's Doldrums, Just A Bad Case Of COVID-19? Pfizer plans direct-to-consumer platform to ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-24 10:13:00 ET If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are unsure about how strong its long-term prospects are, which ...
2024-07-24 10:08:31 ET DENVER, Colo., Jul 24, 2024 ( 247marketnews.com )- Sangamo Therapeutics, Inc. (Nasdaq: SGMO ) expounded on Pfizer’s (NYSE: PFE ) positive topline results from their Phase 3 AFFINE trial (NCT04370054) evaluating giroctocogene fitelparvovec, an invest...
2024-07-24 09:00:21 ET Pfizer Inc. (PFE) declaring a stock dividend of $0.42 per share on Ex-Date : July 25, 2024. Shareholders on record as of July 26, 2024 are eligible for the dividend. The payment date is scheduled for September 03, 2024, and the declaration was officially made ...